NCT06321861

Brief Summary

The main objective of the study is to evaluate the influence of caffeine intake on participants' energetic arousal, affect, motivation to achieve a training goal, satisfaction with training, and the sense of agency during training. Consequently, participants will engage in three sessions: caffeine, placebo, and no substance (in counterbalanced order). During each session, their affective and motivational states will be assessed, along with the performance of a standardized physical exercise test. The investigators hypothesize that participants who consume caffeine (caffeine condition) will exhibit higher levels of energy and motivation compared to the other two groups. Additionally, they are expected to experience greater optimism and expectancy regarding their training goals and achieve better results in the physical exercise test. A secondary aim of the study is to examine the impact of genetic variability on motivational and affective states of participants, as well as their performance in the physical exercise test after caffeine. The investigators will assess the CYP1A2 (-163C \> A, rs762551; characterized such as "fast" (AA genotype) and "slow" caffeine metabolizers (C-carriers)) and ADORA2A (1976T \> C; rs5751876; characterized by "high" (TT genotype) or "low" sensitivity to caffeine (C-carriers)).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

January 19, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 20, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

January 17, 2024

Last Update Submit

March 13, 2024

Conditions

Keywords

caffeineenergizationmotivationeffortaffectphysical exercisearousal

Outcome Measures

Primary Outcomes (16)

  • Energetic arousal pre-test

    Self-reported energetic arousal contrasting vigour with fatigue, measured with the energetic arousal sub-scale of the University of Wales Institute of Science and Technology Mood Adjective Checklist. The values range from 1-4; higher scores indicate greater energetic arousal.

    Right before the intervention

  • Energetic arousal post-test

    Self-reported energetic arousal measured with the energetic arousal sub-scale of the University of Wales Institute of Science and Technology Mood Adjective Checklist. The values range from 1-4; higher scores indicate greater energetic arousal. The change relative to the pre-test will be analyzed.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Optimism

    Situational optimism (expectancy of positive outcomes) measured with 4 items were participants rate the extent to which they: 1) are positively oriented. 2) are full of optimism. 3) can achieve what I set out to do. 4) are capable of a lot. Responses are given on a 1-7 Likert scale. Higher scores indicate greater optimism. The mean of these items will be computed and the change relative to the pre-test will be analyzed.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Motivation

    Motivation to accomplish one's training goals measured with a question where participants rate the extent to which they are motivated to achieve the best result in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 Likert scale. Higher scores indicate greater motivation.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Determination

    Determination to accomplish one's training goals measured with 4 items: 1) During training, everything else will become irrelevant for \[the participant\[. 2) \[The participant\] will put a lot of energy into the training. 3) \[The participant\] will do everything in their power to achieve the training goal. 4) \[The participant\] will reach the training goal even if it requires a great effort. 5) \[The participant\] will train despite fatigue. Participants respond to each item on a 1-7 Likert scale. Higher scores indicate greater determination.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Relative outcome expectancy

    Expectancy of the training results measured with a question: In relation to participants' typical result, what result do they expect in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = definitely worse than usual and 7 = definitely better than usual. Higher scores indicate more positive outcome expectations.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Success probability

    Subjective probability of attaining the best result measured with a question: How likely do participants think it is that they will achieve the best result in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = completely unlikely and 7 = certain. Higher scores indicate greater probability of success.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Prospective effort

    Participants' willingness to invest effort in the training measured with a question: How much effort are participants planning to invest in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond on a 0-100% scale. Higher scores indicate greater willingness to invest effort.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Agency

    Sense of agency measured with two questions: 1) Do participants feel in control over the outcome in..., 2) Do participants feel in control over their performance in... Participants respond to each question in relation to each test outcome: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Responses are given on 1-6 scale anchored 1 = no control and 7 = complete control. Higher scores indicate greater sense of agency.

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Performance in the 1RM test

    Participants' performance in the one-repetition maximum test in bench press \[number of kg\]

    60 minutes after taking the capsule (waiting in the no-intervention condition)

  • Performance in the bar velocity in the bench press test

    Participants' performance in the bar velocity during 3 sets of 3 repetitions in the bench press exercise \[m/s\]

    60 minutes after taking the capsule (waiting in the no-intervention condition)

  • Performance in the strength-endurance test

    Participants' performance in the strength-endurance test in bench press test (number of repetitions)

    60 minutes after taking the capsule (waiting in the no-intervention condition)

  • Performance in the countermovement jump test

    Participants' performance in the countermovement jump test (number of cm)

    60 minutes after taking the capsule (waiting in the no-intervention condition)

  • Satisfaction with the results

    Participants' satisfaction with their training results measured with a question: How satisfied are participants with their results in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = definitely unsatisfied to 7 = definitely satisfied. Higher scores indicate greater satisfaction with the results.

    Immediately after the physical exercise test

  • Retrospective effort

    Participants' assessment of effort invested in the training measured with a question: How much effort did participants invest in:1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond on a 0-100% scale. Higher scores indicate greater effort.

    Immediately after the physical exercise test

  • Retrospective agency

    Sense of agency measured with two questions: 1) Did participants feel in control over the outcome in..., 2) Did participants feel in control over their performance in... Participants respond to each question in relation to each test outcome: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Responses are given on 1-6 scale anchored 1 = no control and 7 = complete control. Higher scores indicate greater sense of agency.

    Immediately after the physical exercise test

Secondary Outcomes (11)

  • Goal importance

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Prospective difficulty

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Expected performance in the 1RM test

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Expected performance in the bar velocity in the bench press test

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • Expected performance in the strength-endurance test

    60 minutes after taking the capsule (waiting in the no-intervention condition); before training

  • +6 more secondary outcomes

Study Arms (3)

Caffeine

EXPERIMENTAL

Participants will take a caffeine pill (3mg/kg of body mass) 60 minutes before the physical exercise test.

Dietary Supplement: Caffeine

Placebo

PLACEBO COMPARATOR

Participants will take a placebo pill 60 minutes before the physical exercise test.

Dietary Supplement: Placebo

No substance

OTHER

Participants receive no pills in this condition before the physical exercise test.

Other: No substance

Interventions

CaffeineDIETARY_SUPPLEMENT

Participants will take one caffeine pill. The dose of caffeine will be calculated based on participants' body mass (3mg/kg body mass). Caffeine will be provided in capsules containing the individual amount of caffeine and will be administered orally 60 min before the onset of the exercise protocol.

Caffeine
PlaceboDIETARY_SUPPLEMENT

Participants will take one pill with no caffeine in it. The manufacturer of the caffeine capsules will also prepare identical placebo capsules filled out with a microcrystalline cellulose. Placebo will be administered orally 60 min before the onset of the exercise protocol.

Placebo

Participants will take no substance. They will just wait 60 minutes and then engage in the exercise protocol.

No substance

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-30 years
  • Caffeine consumption
  • Engagement in physical activity.

You may not qualify if:

  • Diagnosed cardiovascular, metabolic, gastrointestinal, or neurological diseases
  • Taking medications or supplements that may affect test results
  • Tobacco smoking
  • Pregnancy
  • Potential allergy to caffeine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Jerzy Kukuczka Academy of Physical Education in Katowice

Katowice, Poland

RECRUITING

Related Publications (2)

  • Matthews G; Jones DM, Chamberlain AG. Refining the measurement of mood: The UWIST mood adjective checklist. British Journal of Psychology, 1990, 81(1): 17-42.

    BACKGROUND
  • Szumowska E, Molinario E, Jaśko K, Hudiyana J, Firdiani NF, Penrod J, Jaume LC, Leander NP, Kreienkamp J, Agostini M, Gruszka A, Szumska I, Stelmaszyńska D, Gola M, Altungy P, Gómez Á, Cacek J, & Kruglanski AW (2023). The Extreme Personality: Individual Differences in Proneness to Motivational Imbalance. Manuscript submitted for publication.

    BACKGROUND

MeSH Terms

Conditions

Motor Activity

Interventions

Caffeine

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Ewa Szumowska

    Jagiellonian University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aleksandra Filip-Stachnik

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Each participant will take part in three similar sessions differing by the substance they receive: caffeine (intervention group), placebo, no substance. Sessions will be about one week apart.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant

Study Record Dates

First Submitted

January 17, 2024

First Posted

March 20, 2024

Study Start

January 19, 2024

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

March 20, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Anonymized IPD will be shared digitally via the Jagiellonian University Repository.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
The data will become available after preparing the article summarizing the study results. The data will be shared for at least 5 years.
Access Criteria
All researchers possessing the link to the data will be able to access it.

Locations